Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sami Chtourou

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 17, 2017
Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human PlasmaCaroline Goussen, Steve Simoneau, Soline Bérend, et al.
Mabs|March 20, 2018
Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation patternNathalie Fournier, Emilie Jacque, Alexandre Fontayne, et al.
Frontiers in Immunology|June 24, 2021
Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus ProphylaxisEmilie Jacque, Claire Chottin, Daphné Laubreton, et al.
Frontiers in Immunology|September 13, 2021
The Dual Targeting of FcRn and FcγRs <i>via</i> Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune PathologiesCéline Monnet, Emilie Jacque, Christophe de Romeuf, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 17, 2017
Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human PlasmaCaroline Goussen, Steve Simoneau, Soline Bérend, et al.
Mabs|March 20, 2018
Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation patternNathalie Fournier, Emilie Jacque, Alexandre Fontayne, et al.
Frontiers in Immunology|June 24, 2021
Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus ProphylaxisEmilie Jacque, Claire Chottin, Daphné Laubreton, et al.
Frontiers in Immunology|September 13, 2021
The Dual Targeting of FcRn and FcγRs <i>via</i> Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune PathologiesCéline Monnet, Emilie Jacque, Christophe de Romeuf, et al.
Pageof 2